Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04832152 · ClinicalTrials.gov registry record · NA

Telehealth Intervention for Autism Spectrum Disorder

A NA study of Autism Spectrum Disorder, sponsored by Thomas Jefferson University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04832152: Recruiting NA study of Autism Spectrum Disorder, sponsored by Thomas Jefferson University.

NCT04832152 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 10 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04832152, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Autism Spectrum Disorder (ASD) is one of the most frequently occurring childhood-onset neurodevelopmental disorders affecting 1 in every 54 children. Most children with ASD experience challenges participating in daily activities (e.g.: eating, sleeping, bathing, grooming, playing, etc.) and receive occupational therapy intervention to address these. The COVID-19 pandemic has restricted in-person therapy for many of these children and there is an urgent need for evidence-based, validated telehealth intervention. This project will adapt an evidence-based occupational therapy intervention, termed OT4ASD to a telehealth delivery model. The aims of the project are to: 1) adapt the existing intervention protocol to a telehealth delivery model, 2) train therapists and evaluate the therapist's ability to conduct OT4ASD, 3) determine if OT4ASD delivered via the telehealth is acceptable and feasible to parents and interventionists; and 4) whether children improve in the daily living skills. OT4ASD follows a systematic protocol and uses active, individually-tailored sensory motor activities that are specifically designed to address the child's needs. The investigators believe this will be the first telehealth manualized protocol to address the sensory motor symptoms of ASD and measure outcomes at the daily life activity and participation levels.

Conditions Studied

Interventions

  • OTHER OT4ASD

Study Locations (1)

New York

  • Rose R. Kennedy Children's Evaluation and Rehabilitation Center (CERC) at Montefiore - The Bronx

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-03-01
Est. Completion 2024-06-30
Phase NA
Thomas Jefferson University

292 total trials

What NCT04832152 shows while recruiting

NCT04832152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which OT4ASD is the first listed.

NCT04832152 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04832152 about?

NCT04832152 is a clinical study titled "Telehealth Intervention for Autism Spectrum Disorder". Autism Spectrum Disorder (ASD) is one of the most frequently occurring childhood-onset neurodevelopmental disorders affecting 1 in every 54 children. Most children with ASD experience challenges participating in daily activities (e.g.: eating, sleeping, bathing, grooming, playing, etc.) and receive ...

What is the current status of trial NCT04832152?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-03-01. Estimated completion is 2024-06-30.

What conditions does trial NCT04832152 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT04832152?

The interventions under investigation include: OT4ASD (OTHER).

Who is sponsoring clinical trial NCT04832152?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04832152 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04832152's enrollment target sits among peer trials

10 216th of 224 higher than 5 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04832152, the US trial registry maintained by the National Library of Medicine. NCT04832152 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.